Shire
Global Innovator in Specialty Biopharmaceuticals.
Employees
Enterprise value
$5.9b
Recent deals
loading funding rounds…
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 100 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | 100 % | 100 % | 100 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | 143100 % | - | - |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Shire
Edit
ACQUISITION by Shire Aug 2015
ACQUISITION by JCR Pharmaceuticals Mar 2020
ACQUISITION by Shire Apr 2007
ACQUISITION by Allergan Jul 2015
ACQUISITION by Shire May 2014
ACQUISITION by Shire Nov 2013
ACQUISITION by Shire Aug 2010
ACQUISITION by Shire Feb 2015